XiaoZhong Wang Selected Research

Neoplasms (Cancer)

1/2023

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

XiaoZhong Wang Research Topics

Disease

1	Neoplasms (Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

1	Trinitrotoluene (TNT)IBA 01/2023

Therapy/Procedure

1	Neoadjuvant Therapy 01/2023
1	Chemoradiotherapy 01/2023